Karl-Dimiter Bissig

Title: Innovations by Karl-Dimiter Bissig

Introduction

Karl-Dimiter Bissig is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of medical research, particularly in liver-related therapies. With a total of 3 patents, his work focuses on innovative solutions for liver function and treatment.

Latest Patents

One of his latest patents is titled "Human liver chimeric mouse with deficient P450 oxidoreductase." This patent describes a chimeric non-human animal that comprises human hepatocytes. The methods outlined in this patent allow for the preparation and utilization of this chimeric animal to screen and identify metabolites for various drugs, especially small molecule drugs that may impact human liver functions and other bodily functions.

Another notable patent is "Antibody based gene therapy with tissue-directed expression." This patent includes methods and compositions aimed at treating medical conditions related to the liver, such as viral infections and liver cancer. The embodiments of this patent provide immunotherapies for delivering polynucleotides locally to the liver, which encode specific gene products, including bispecific antibodies targeting certain liver antigens.

Career Highlights

Karl-Dimiter Bissig is affiliated with the Baylor College of Medicine, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on liver health and disease treatment.

Collaborations

He has collaborated with notable colleagues, including Robert Layne Kruse and Stephen M G Gottschalk, further enhancing the scope and reach of his research.

Conclusion

Karl-Dimiter Bissig's contributions to medical research through his patents reflect his commitment to improving liver health and treatment options. His innovative approaches are paving the way for future advancements in the field.